• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Cellebrite DI Ltd.

    5/23/25 4:19:11 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology
    Get the next $CLBT alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001547134
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    CELLEBRITE DI LTD
    SEC File Number
    001-40772
    Address of Issuer
    94 Shlomo Shmelzer Road
    Petah Tikva
    ISRAEL
    4970602
    Phone
    972-73-394-8000
    Name of Person for Whose Account the Securities are To Be Sold
    DAVID GEE
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    COMMON
    Morgan Stanley Smith Barney LLC Executive Financial Services
    1 New York Plaza
    8th Floor
    New York � NY � 10004
    12150203026.5023947006205/23/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common05/20/2025Restricted Stock UnitsIssuerCheckbox not checked1215005/20/2025N/A

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    DAVID GEE
    94 Shlomo Shmelzer Road
    Petah Tikva � L3 � 4970602
    Common05/21/202510555179962.75

    144: Remarks and Signature

    Remarks
    Date of Notice
    05/23/2025
    Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
    02/21/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ David Gee

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $CLBT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CLBT

    DatePrice TargetRatingAnalyst
    3/28/2024$13.00 → $13.50Buy
    Needham
    3/13/2024Mkt Perform → Outperform
    William Blair
    2/16/2024$9.00 → $12.00Neutral → Buy
    BofA Securities
    7/19/2023$11.00Buy
    Craig Hallum
    8/12/2022$6.50 → $6.00Buy → Neutral
    BofA Securities
    8/12/2022Outperform → Mkt Perform
    William Blair
    2/24/2022$10.50Overweight
    JP Morgan
    2/11/2022$10.50Buy
    Deutsche Bank
    More analyst ratings

    $CLBT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cellebrite Announces Second-Quarter 2025 Results

    Thomas E. Hogan Named CEO ARR grew 21% to $418.9 million; Revenue grew 18% to $113.3 million Net income of $19.5 million supports non-GAAP net income of $30.8 million and adjusted EBITDA of $27.9 million, 24.6% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and six months ending June 30, 2025 and the appointment of Thomas E. Hogan as the Company's CEO. "Cellebrite delivered a strong balance of top-line growth, profitability and cash flow," stated Thomas E. H

    8/14/25 7:00:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    U.S. Department of Justice to Sponsor Cellebrite for FedRAMP ATO

    TYSONS CORNER, Va., July 23, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the U.S. Department of Justice (DOJ) will serve as the official sponsoring agency for the platform's pursuit of a FedRAMP High authorization. Cellebrite announced its intent to pursue FedRAMP authorization in 2024. In 2025, Cellebrite Government Cloud (CGC) was reviewed by a Third-Party Assessment Organization (3PAO), and the FedRAMP Program Management Office (PMO) prepared a Readiness Assessment Report (RAR), which granted Cellebrite Government Cloud FedRAMP High Ready status. DOJ's sponsorship is th

    7/23/25 8:30:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Cellebrite Names David Barter Chief Financial Officer

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that David Barter, a proven finance executive with extensive public company CFO experience in technology and software, has been appointed CFO, effective immediately. He succeeds Dana Gerner, who has served as Cellebrite's CFO since 2014. Gerner will remain in an active advisory role to support the transition until the Company reports its second-quarter 2025 financial results. As CFO, Barter is responsible for the Company's financial operations, including financial planning, acco

    7/8/25 8:30:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    $CLBT
    SEC Filings

    View All

    SEC Form 6-K filed by Cellebrite DI Ltd.

    6-K - Cellebrite DI Ltd. (0001854587) (Filer)

    8/15/25 9:01:58 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by Cellebrite DI Ltd.

    6-K - Cellebrite DI Ltd. (0001854587) (Filer)

    8/14/25 7:10:21 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    SEC Form 6-K filed by Cellebrite DI Ltd.

    6-K - Cellebrite DI Ltd. (0001854587) (Filer)

    7/8/25 8:45:10 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    $CLBT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham reiterated coverage on Cellebrite DI with a new price target

    Needham reiterated coverage of Cellebrite DI with a rating of Buy and set a new price target of $13.50 from $13.00 previously

    3/28/24 8:25:08 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Cellebrite DI upgraded by William Blair

    William Blair upgraded Cellebrite DI from Mkt Perform to Outperform

    3/13/24 7:29:30 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Cellebrite DI upgraded by BofA Securities with a new price target

    BofA Securities upgraded Cellebrite DI from Neutral to Buy and set a new price target of $12.00 from $9.00 previously

    2/16/24 7:23:02 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    $CLBT
    Leadership Updates

    Live Leadership Updates

    View All

    Cellebrite to Acquire Corellium

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 05, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its agreement to acquire Corellium, a leader in Arm-based virtualization software. This combination will set a new standard for digital investigations and the security of smart devices including iOS, Android, automotive systems and any Arm-based IoT device. Customers across public safety, defense, intelligence and private sectors will benefit from: Accelerated identification of mobile vulnerabilities and exploitsIndustry-first ability to visualize and interact with virtual dev

    6/5/25 7:30:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Cellebrite Appoints Michael D. Capellas to Board of Directors as Lead Independent Director

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) --  Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a series of Board updates to support the Company's continued growth into 2025 and beyond. As previously detailed on November 6, 2024, Thomas E. Hogan has been appointed interim CEO to begin 2025 as part of a planned leadership transition. In conjunction with stepping into this position, Mr. Hogan remains on the Company's Board of Directors and plans to revert to his position as chairman upon the eventual appointment of a new CEO. As part of Cellebrite's ongoing commitment to

    1/6/25 8:00:00 AM ET
    $CLBT
    $CSCO
    Computer Software: Prepackaged Software
    Technology
    Computer Communications Equipment
    Telecommunications

    Yossi Carmil to Step Down as CEO After Nearly 20 Years

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil's decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024. The Board has initiated a formal search for a new CEO, retaining an executive recruiting firm to advance this effort. Thomas E. Hogan, Cellebrite's executive chairman, will serve as interim CEO upon Carmil's departure and until the search is complete and a new CEO joins Cellebrite. "Cellebrite is indebted to

    11/6/24 8:20:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    $CLBT
    Financials

    Live finance-specific insights

    View All

    Cellebrite Announces Second-Quarter 2025 Results

    Thomas E. Hogan Named CEO ARR grew 21% to $418.9 million; Revenue grew 18% to $113.3 million Net income of $19.5 million supports non-GAAP net income of $30.8 million and adjusted EBITDA of $27.9 million, 24.6% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and six months ending June 30, 2025 and the appointment of Thomas E. Hogan as the Company's CEO. "Cellebrite delivered a strong balance of top-line growth, profitability and cash flow," stated Thomas E. H

    8/14/25 7:00:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Cellebrite Names David Barter Chief Financial Officer

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, July 08, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that David Barter, a proven finance executive with extensive public company CFO experience in technology and software, has been appointed CFO, effective immediately. He succeeds Dana Gerner, who has served as Cellebrite's CFO since 2014. Gerner will remain in an active advisory role to support the transition until the Company reports its second-quarter 2025 financial results. As CFO, Barter is responsible for the Company's financial operations, including financial planning, acco

    7/8/25 8:30:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Cellebrite Announces First-Quarter 2025 Results

    First-Quarter 2025 revenue of $107.5 million grew 20% primarily due to 21% growth in subscription revenue ARR grew 23% to $408.0 million First-Quarter 2025 adjusted EBITDA of $23.7 million, 22.0% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 14, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three months ending March 31, 2025. "Cellebrite delivered strong 23% ARR growth while pairing solid revenue expansion with prudent spending to drive 34% year-over-year growth in adjusted EBITDA and a 22% margin," stated Thomas

    5/14/25 7:00:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    $CLBT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Cellebrite DI Ltd.

    SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

    9/17/24 4:33:52 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Cellebrite DI Ltd.

    SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

    8/29/24 6:07:01 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Cellebrite DI Ltd. (Amendment)

    SC 13G/A - Cellebrite DI Ltd. (0001854587) (Subject)

    3/12/24 12:38:56 PM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology